Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aridis Pharmaceuticals, Inc. | 1,378,639 | reported | 24 Jun 2024 | tx 12+1,485,986−15,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Jun 2024 | PURCHASE | Aridis Pharmaceuticals, Inc. | 714,286 | 0.07 USD | first after silence |
| 18 Sept 2023 | GRANT_AWARD | Aridis Pharmaceuticals, Inc. | 30,000 | 0.00 USD | deriv |
| 05 Jun 2023 | EXERCISE | Aridis Pharmaceuticals, Inc. | 15,000 | — | |
| 04 May 2023 | GRANT_AWARD | Aridis Pharmaceuticals, Inc. | 100,000 | 0.00 USD | deriv |
| 05 Jun 2023 | EXERCISE | Aridis Pharmaceuticals, Inc. | 15,000 | — | deriv |
| 05 Dec 2022 | GRANT_AWARD | Aridis Pharmaceuticals, Inc. | 30,000 | 0.00 USD | deriv |
| 07 Jun 2022 | GRANT_AWARD | Aridis Pharmaceuticals, Inc. | 88,360 | 0.00 USD | deriv |
| 27 Jul 2021 | PURCHASE | Aridis Pharmaceuticals, Inc. | 5,000 | 5.11 USD | |
| 12 May 2021 | GRANT_AWARD | Aridis Pharmaceuticals, Inc. | 53,340 | 0.00 USD | deriv |
| 03 Apr 2020 | EXERCISE | Aridis Pharmaceuticals, Inc. | 50,000 | 0.00 USD | deriv |
| 20 Feb 2019 | GRANT_AWARD | Aridis Pharmaceuticals, Inc. | 200,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 24 Jun 2024.